Healthcare Services

Viral Vector Services Market Forecast Through 2030 with Industry Growth Insights

April 28, 2026April 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Viral Vector Service Market Compare Between 2026 And 2030?

The viral vector service market has seen rapid expansion over recent years. Projections indicate it will increase from $2.53 billion in 2025 to $3.14 billion in 2026, achieving a compound annual growth rate (CAGR) of 24.2%. Historically, this growth can be ascribed to several factors, including the rising utilization of viral vectors in biomedical research, the broadening scope of gene delivery applications, the early embrace of outsourced vector services, the development of translational medicine initiatives, and the establishment of standardized production procedures.

The viral vector service market size is anticipated to undergo significant expansion in the upcoming years. It is predicted to reach $7.41 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 23.9%. This projected growth during the forecast period is attributed to the increasing commercialization of gene-based therapies, a rising demand for customized vector solutions, the expansion of contract service partnerships, evolving regulatory requirements for viral vectors, and heightened investment in advanced vector technologies. Key trends during this timeframe encompass an increasing demand for end-to-end viral vector services, the rising adoption of integrated development and manufacturing models, a growing focus on quality-controlled vector production, the expansion of custom vector design capabilities, and an enhanced emphasis on regulatory compliance services.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30430&type=smp

Which Strong Drivers Are Impacting The Viral Vector Service Market Growth?

The increasing prevalence of infectious diseases is expected to propel the growth of the viral vector services market. These illnesses, caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, can spread directly or indirectly between individuals. The incidence of infectious diseases is rising, partly due to increased travel facilitating the rapid global spread of pathogens. Viral vector services are vital in managing these diseases by providing reliable platforms for developing vaccines and gene-based therapeutics. They enable the efficient delivery of genetic material to target cells, thereby accelerating the creation of effective treatments and enhancing public health responses. For instance, according to the UK Health Security Agency in February 2024, tuberculosis cases in England increased to 4,850 in 2023, marking a 10.7% rise from 4,380 cases in 2022. This growing burden of infectious diseases is consequently driving the demand in the viral vector services market.

How Is The Viral Vector Service Market Segmented Across Different Segment Categories?

The viral vector service market covered in this report is segmented –

1) By Service Type: Process Development, Manufacturing, Quality Control

2) By Vector Type: Adenoviral Vectors, Lentiviral Vectors, Adeno-Associated Viral Vectors, Retroviral Vectors, Other Vector Types

3) By Application: Gene Therapy, Vaccinology, Oncology, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Research Institutes, Other End-Users

Subsegments:

1) By Process Development: Vector Design, Assay Development, Cell Line Development, Process Optimization

2) By Manufacturing: Upstream Production, Downstream Purification, Formulation Development, Scale-Up Production

3) By Quality Control: Analytical Testing, Safety Testing, Potency Testing, Stability Testing

Which Trends Are Contributing To Changes In The Viral Vector Service Market?

Major companies operating in the viral vector service market are focusing on innovation in lentiviral vector design and manufacturing, such as fourth-generation vector systems, to enhance payload capacity, potency, and safety while streamlining the development of complex gene therapies. Fourth-generation vector systems refer to advanced lentiviral delivery technologies engineered with improved safety profiles, optimized gene packaging capabilities, and modular components that support scalable plug-and-play manufacturing for cell and gene therapies. For instance, in May 2023, Oxford Biomedica plc, a UK-based viral vector contract development and manufacturing organization (CDMO), launched the TetraVecta system. The system improves vector quality, potency, and packaging efficiency while incorporating advanced safety features. It enables the creation of high-titer, stable producer cell lines, supporting scalable in vivo gene therapy development. TetraVecta streamlines the manufacturing process, reducing production timelines and enhancing overall efficiency for gene therapy programs.

Which Organizations Play A Role In The Viral Vector Service Market Landscape?

Major companies operating in the viral vector service market are Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, FUJIFILM Diosynth Biotechnologies, Danaher Corporation, Sartorius AG, Charles River Laboratories Inc., Takara Bio Inc., Oxford Biomedica plc, ProBioGen AG, NorthX Biologics Ltd., PackGene Biotech Ltd., Ascend Advanced Therapies Ltd., VectorBuilder Inc., ViroCell Biologics Ltd., Genezen Ltd., Scorpius BioManufacturing Ltd., VGXI Inc., Creative Biogene Ltd., ReiThera Ltd., Tailored Genes Ltd., CoJourney Ltd., InnovaVector Ltd.

Get The Full Viral Vector Service Market Report:

https://www.thebusinessresearchcompany.com/report/global-viral-vector-service-market-report

Which Region Represents The Largest Share Of The Viral Vector Service Market?

North America was the largest region in the viral vector service market in 2025. The regions covered in the viral vector service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Viral Vector Service Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/global-viral-vector-service-market-report

Browse Through More Reports Similar to the Global Viral Vector Service Market 2026, By The Business Research Company

Viral Vector Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report

Viral And Non Viral Vector Manufacturing Market Report

https://www.thebusinessresearchcompany.com/report/viral-and-non-viral-vector-manufacturing-global-market-report

Antivirus Software Market Report

https://www.thebusinessresearchcompany.com/report/antivirus-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795